BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1139228)

  • 1. Editorial: New prospects in renal hypertension.
    Br Med J; 1975 Jul; 3(5975):59-60. PubMed ID: 1139228
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
    Stumpe KO; Overlack A; Krück F
    Herz; 1978 Oct; 3(5):305-12. PubMed ID: 721057
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Mechanisms in hypertension.
    Lancet; 1975 Sep; 2(7932):445. PubMed ID: 51247
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
    Novikova LS; Arabidze GG
    Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO; Kolloch RE; Redlich B; Vetter H; Krück F
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():167-76. PubMed ID: 613561
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].
    Beckerhoff R; Vetter W; Furrer J; Tuma J; Zàruba K; Vetter H; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1738-41. PubMed ID: 1013696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic functional examination in arterial hypertension].
    Stumpe KO; Kolloch R; Overlack A
    Internist (Berl); 1977 Nov; 18(11):594-600. PubMed ID: 23361
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-hypertensive effect of the angiotensin II antagonist saralasin acetate, a diagnostic criterion of renovascular hypertension].
    Wessels F; Wagner H; Erhard R; Peters P; Losse H
    Med Welt; 1978 Mar; 29(9):339-41. PubMed ID: 634129
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin blockade in hypertension.
    Streeten DH; Anderson GH
    Ann Intern Med; 1977 Mar; 86(3):353-4. PubMed ID: 842997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
    VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
    Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic prospects in the use of saralasin].
    Pigliucci GM; Valenza M; Rosati F; Cagossi M
    Chir Patol Sper; 1979 Oct; 27(5):491-7. PubMed ID: 261945
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angiotensin blockade in the diagnosis of hypertension].
    Keim HJ; Case DB; Wallace JM; Sealry JE; Laragh JH
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():205-6. PubMed ID: 613573
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors of the renin-angiotensin system. Effects on blood pressure, aldosterone secretion and renal function.
    Atlas SA; Niarchos AP; Case DB
    Am J Nephrol; 1983; 3(2-3):118-27. PubMed ID: 6191567
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
    Cappelli G; Vagge R; Lamperi S
    Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensen antagonist in rats with acute, subacute, and chronic two-kidney renal hypertension.
    Carretero OA; Gulati OP
    J Lab Clin Med; 1978 Feb; 91(2):264-71. PubMed ID: 621427
    [No Abstract]   [Full Text] [Related]  

  • 19. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.